Cargando…
Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the Sost gene hours after stimulation. Using mouse model...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032393/ https://www.ncbi.nlm.nih.gov/pubmed/33779549 http://dx.doi.org/10.7554/eLife.64393 |
_version_ | 1783676210063081472 |
---|---|
author | Gould, Nicole R Williams, Katrina M Joca, Humberto C Torre, Olivia M Lyons, James S Leser, Jenna M Srikanth, Manasa P Hughes, Marcus Khairallah, Ramzi J Feldman, Ricardo A Ward, Christopher W Stains, Joseph P |
author_facet | Gould, Nicole R Williams, Katrina M Joca, Humberto C Torre, Olivia M Lyons, James S Leser, Jenna M Srikanth, Manasa P Hughes, Marcus Khairallah, Ramzi J Feldman, Ricardo A Ward, Christopher W Stains, Joseph P |
author_sort | Gould, Nicole R |
collection | PubMed |
description | The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the Sost gene hours after stimulation. Using mouse models and rodent cell lines, we describe the rapid, minute-scale post-translational degradation of sclerostin protein by the lysosome following mechanical load and PTH. We present a model, integrating both new and established mechanically and hormonally activated effectors into the regulated degradation of sclerostin by lysosomes. Using a mouse forelimb mechanical loading model, we find transient inhibition of lysosomal degradation or the upstream mechano-signaling pathway controlling sclerostin abundance impairs subsequent load-induced bone formation by preventing sclerostin degradation. We also link dysfunctional lysosomes to aberrant sclerostin regulation using human Gaucher disease iPSCs. These results reveal how bone anabolic cues post-translationally regulate sclerostin abundance in osteocytes to regulate bone formation. |
format | Online Article Text |
id | pubmed-8032393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-80323932021-04-12 Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein Gould, Nicole R Williams, Katrina M Joca, Humberto C Torre, Olivia M Lyons, James S Leser, Jenna M Srikanth, Manasa P Hughes, Marcus Khairallah, Ramzi J Feldman, Ricardo A Ward, Christopher W Stains, Joseph P eLife Cell Biology The downregulation of sclerostin in osteocytes mediates bone formation in response to mechanical cues and parathyroid hormone (PTH). To date, the regulation of sclerostin has been attributed exclusively to the transcriptional downregulation of the Sost gene hours after stimulation. Using mouse models and rodent cell lines, we describe the rapid, minute-scale post-translational degradation of sclerostin protein by the lysosome following mechanical load and PTH. We present a model, integrating both new and established mechanically and hormonally activated effectors into the regulated degradation of sclerostin by lysosomes. Using a mouse forelimb mechanical loading model, we find transient inhibition of lysosomal degradation or the upstream mechano-signaling pathway controlling sclerostin abundance impairs subsequent load-induced bone formation by preventing sclerostin degradation. We also link dysfunctional lysosomes to aberrant sclerostin regulation using human Gaucher disease iPSCs. These results reveal how bone anabolic cues post-translationally regulate sclerostin abundance in osteocytes to regulate bone formation. eLife Sciences Publications, Ltd 2021-03-29 /pmc/articles/PMC8032393/ /pubmed/33779549 http://dx.doi.org/10.7554/eLife.64393 Text en © 2021, Gould et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cell Biology Gould, Nicole R Williams, Katrina M Joca, Humberto C Torre, Olivia M Lyons, James S Leser, Jenna M Srikanth, Manasa P Hughes, Marcus Khairallah, Ramzi J Feldman, Ricardo A Ward, Christopher W Stains, Joseph P Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
title | Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
title_full | Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
title_fullStr | Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
title_full_unstemmed | Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
title_short | Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
title_sort | disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032393/ https://www.ncbi.nlm.nih.gov/pubmed/33779549 http://dx.doi.org/10.7554/eLife.64393 |
work_keys_str_mv | AT gouldnicoler disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT williamskatrinam disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT jocahumbertoc disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT torreoliviam disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT lyonsjamess disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT leserjennam disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT srikanthmanasap disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT hughesmarcus disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT khairallahramzij disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT feldmanricardoa disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT wardchristopherw disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein AT stainsjosephp disparateboneanaboliccuesactivateboneformationbyregulatingtherapidlysosomaldegradationofsclerostinprotein |